ATI RN
ATI Mental Health Practice A
1. A patient with major depressive disorder is being treated with electroconvulsive therapy (ECT). The nurse should monitor the patient for which common side effect?
- A. Memory loss
- B. Hypertension
- C. Weight gain
- D. Hyperglycemia
Correct answer: A
Rationale: Memory loss, especially short-term memory loss, is a common side effect associated with electroconvulsive therapy (ECT). During ECT treatment, the electrical currents passed through the brain can disrupt short-term memory formation. This side effect is usually temporary, but patients should be closely monitored for any changes in memory function during and after the treatment. Choices B, C, and D are incorrect because they are not commonly associated with ECT. Hypertension, weight gain, and hyperglycemia are not typically observed as side effects of ECT.
2. A healthcare professional is preparing to administer an intermittent enteral feeding to a client who has a nasogastric tube. Which of the following actions should the healthcare professional take first?
- A. Check the residual volume before administering the feeding
- B. Elevate the head of the bed to 30 degrees
- C. Flush the tube with 10 mL of sterile water
- D. Verify the client's tube placement
Correct answer: D
Rationale: Verifying the client's tube placement is the priority before administering any enteral feeding. This step ensures that the tube is correctly positioned in the stomach or intestines, minimizing the risk of complications such as aspiration. Checking the residual volume, elevating the head of the bed, and flushing the tube are important steps but should occur after confirming the tube placement to ensure the feeding is delivered safely and effectively.
3. When teaching a patient to take their own pulse, which medication should the nurse instruct them to monitor? (Hint: if pulse is <60 or >100, the patient should contact their healthcare provider before taking the medication)
- A. Digoxin
- B. Lithium
- C. Montelukast
- D. Phenytoin
Correct answer: A
Rationale: It is essential for patients taking Digoxin to monitor their pulse regularly. If their pulse falls below 60 or exceeds 100 beats per minute, they should contact their healthcare provider immediately. This is crucial due to Digoxin's potential to affect heart rate, making pulse monitoring a vital aspect of patient care while on this medication.
4. How should a healthcare provider monitor a patient receiving heparin therapy?
- A. Monitor aPTT
- B. Monitor platelet count
- C. Monitor sodium levels
- D. Monitor calcium levels
Correct answer: A
Rationale: The correct answer is to monitor aPTT (activated partial thromboplastin time) when a patient is receiving heparin therapy. aPTT monitoring is essential for assessing the therapeutic effectiveness of heparin, ensuring the patient is within the desired therapeutic range to prevent both clotting and bleeding. Monitoring platelet count (Choice B) is important for assessing for heparin-induced thrombocytopenia but is not the primary monitoring parameter for heparin therapy. Monitoring sodium levels (Choice C) and calcium levels (Choice D) are not directly related to assessing the therapeutic effectiveness or potential side effects of heparin therapy.
5. How should contaminated instruments used during delivery be handled?
- A. Wash with soap and water and soak in 0.5% chlorine solution for 10 minutes
- B. Soak in 0.5% chlorine solution for 30 minutes
- C. Wash with soap and water and boil for 2 hours
- D. Soak in 0.5% chlorine solution for 10 minutes
Correct answer: B
Rationale: When dealing with contaminated instruments used during delivery, it is crucial to soak them in a 0.5% chlorine solution for 30 minutes to ensure proper disinfection. This practice helps eliminate potential pathogens and ensures the safety of both the healthcare provider and the patient.
Similar Questions
Access More Features
ATI Basic
- 50,000 Questions with answers
- All ATI courses Coverage
- 30 days access @ $69.99
ATI Basic
- 50,000 Questions with answers
- All ATI courses Coverage
- 90 days access @ $149.99